Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.
about
Photodynamic Therapy in Non-Gastrointestinal Thoracic MalignanciesConcurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literatureCombining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLCFour-dimensional stereotactic radiotherapy for early stage non-small cell lung cancer: a comparative planning study.Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patientsPhotodynamic therapy of disseminated non-small cell lung carcinoma in a murine modelImpact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer.Pleural Photodynamic Therapy and Surgery in Lung Cancer and Thymoma Patients with Pleural Spread.Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy--retrospective analysis of 203 casesAccelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer.Cancer-related anemia: biological findings, clinical implications and impact on quality of life.Reasons for palliative treatments in stage III non-small-cell lung cancer: what contribution is made by time-dependent changes in tumour or patient status?Concurrent chemoradiotherapy for elderly patients with stage III non-small cell lung cancer.Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer PatientsFailure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: a competing risks analysisA Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients.Senior adult oncology.Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis.Determinants of survival in advanced non--small-cell lung cancer in the era of targeted therapiesLung cancer and women.EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 Patients.Efficacy of the smaller target volume for stage III non-small cell lung cancer treated with intensity-modulated radiotherapy.Weight gain as a surrogate marker of longer survival in advanced non-small cell lung cancer patients.Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries.Radiotherapy and chemotherapy for elderly patients with stage I-II unresected lung cancer.Radiotherapy alone versus radiochemotherapy in patients with stage IIIA adenocarcinoma (ADC) of the lung.Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer.Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome.Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the HooLung cancer: locally advanced NCSLC in the elderly: which treatment?Increased CYFRA 21-1, CEA and NSE are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive Partitioning Risk Stratification Analysis.
P2860
Q26775131-BEFF39C3-AC8A-408B-9443-3F3870E4F46EQ26851579-6C437BEB-6407-4A9F-85BD-8EFA4691BAE7Q26852202-631BE22B-B3D7-46A1-ADC6-DBE6BC1235A8Q33315026-18B4C76F-5295-46F1-B909-BFEA50275273Q33389562-E68E4BD6-488E-44CE-B7F2-C068F7DDB1FDQ34068178-E6A8054A-DF32-4D34-B06A-061AC66B0877Q34390410-9B590DC6-B75A-4F40-AD11-6412535DB5CCQ35699917-546DDB55-793B-4562-9E3E-A5E83132DF92Q35810871-685D5948-86E7-414C-851B-6FE05B8BEFF8Q35939945-4A4210D8-5BDD-4140-89C9-817722721246Q36108558-E19A5D02-8086-4E29-8353-07846926E478Q36394587-A63F68E3-B337-4071-9FA6-CA4B77DFDAE2Q36395262-C5CDB563-AE20-483D-86E8-D898920479D0Q36536988-416601B3-9943-48E0-8E23-0C4922FEF219Q36643619-D88B88DA-57B2-4165-B7FD-A3CD7234923FQ36672750-D42C1F24-18B1-43AC-92C7-DBA34700E681Q36851424-3D97957D-30C5-4BDF-851F-1BBBFC943036Q36863492-166B35FE-075C-429F-A53F-408CD06F18C6Q37146779-8AA6957B-DCE7-4C3C-8CB3-C769FAAAD366Q37298672-EC2B4C7E-58BB-480B-A811-B7B6C629D3F4Q37589341-9D37BE08-2D59-48D4-8EF2-6126E6DC7E83Q39737188-8B83EEFB-66E9-4940-8CFC-0CBAC1531A27Q40257373-4DD97DAB-782B-464A-8219-CC7168FFC8DFQ41544840-9AD63813-50B8-440D-8621-D720CDA78753Q41550760-C99D8646-46DE-4C70-91F4-BD4D1D095D19Q42121077-7E1EF85C-5608-4205-AB34-92560E9B3DD7Q43960299-DD248246-492A-418E-8D19-5177A5F4DF19Q47643885-E3B1C316-83C6-4C5A-9C40-3069DEC09014Q47769995-284CD355-F7D5-4999-9954-6125BDF69AC3Q48002323-5E6EF0DB-BDCF-48B9-93D0-86BD5E5882E5Q53199885-0AB2171E-1B8B-4B01-B7E9-00ECC60AF0E8Q54403574-A8970004-5E8E-4E74-AE3C-FDE9292E48C7Q55529918-E11337C0-CA41-451A-914F-18082D95931A
P2860
Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Recursive partitioning analysi ...... roups with different survival.
@ast
Recursive partitioning analysi ...... roups with different survival.
@en
type
label
Recursive partitioning analysi ...... roups with different survival.
@ast
Recursive partitioning analysi ...... roups with different survival.
@en
prefLabel
Recursive partitioning analysi ...... roups with different survival.
@ast
Recursive partitioning analysi ...... roups with different survival.
@en
P2093
P1476
Recursive partitioning analysi ...... roups with different survival.
@en
P2093
Byhardt RW
Werner-Wasik M
P304
P356
10.1016/S0360-3016(00)00801-4
P407
P577
2000-12-01T00:00:00Z